Showing results (201-210 of 280) with videos related to

Sort By:
Pageof 28
Blood Neoplasia|August 14, 2025
Checkpoint immunotherapy is associated with preferential activation of tumor antigen-specific CD4+ T cells in MDSElizabeth A Griffiths, Pragya Srivastava, Eduardo Cortes Gomez, et al.
Blood|January 18, 2011
Phase 1 and pharmacokinetic study of bolus-infusion flavopiridol followed by cytosine arabinoside and mitoxantrone for acute leukemiasJudith E Karp, B Douglas Smith, Linda S Resar, et al.
Leukemia Research|September 5, 2017
Timed sequential therapy for acute myelogenous leukemia: Results of a retrospective study of 301 patients and review of the literatureKelly J Norsworthy, Amy E DeZern, Hua-Ling Tsai, et al.
Cancer Research|June 17, 2006
Combined DNA methyltransferase and histone deacetylase inhibition in the treatment of myeloid neoplasmsSteven D Gore, Stephen Baylin, Elizabeth Sugar, et al.
The Lancet. Oncology|August 23, 2015
Safety and tolerability of guadecitabine (SGI-110) in patients with myelodysplastic syndrome and acute myeloid leukaemia: a multicentre, randomised, dose-escalation phase 1 studyJean-Pierre J Issa, Gail Roboz, David Rizzieri, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 27, 2017
NY-ESO-1 Vaccination in Combination with Decitabine Induces Antigen-Specific T-lymphocyte Responses in Patients with Myelodysplastic SyndromeElizabeth A Griffiths, Pragya Srivastava, Junko Matsuzaki, et al.
Transfusion|November 24, 2016
Wide variations in blood product transfusion practices among providers who care for patients with acute leukemia in the United StatesAlexander B Pine, Eun-Ju Lee, Mikkael Sekeres, et al.
Leukemia Research|September 26, 2021
Phase 1 study of the histone deacetylase inhibitor entinostat plus clofarabine for poor-risk Philadelphia chromosome-negative (newly diagnosed older adults or adults with relapsed refractory disease) acute lymphoblastic leukemia or biphenotypic leukemiaHetty E Carraway, Yazeed Sawalha, Ivana Gojo, et al.
British Journal of Haematology|June 17, 2025
Efficacy and safety of oral decitabine/cedazuridine in the chronic myelomonocytic leukaemia subpopulations from phase 2 and 3 studiesMichael R Savona, Olatoyosi Odenike, Gail J Roboz, et al.
Leukemia|February 27, 2020
Inhibition of LSD1 in MDS progenitors restores differentiation of CD141Hi conventional dendritic cellsPragya Srivastava, Stephanie L Tzetzo, Eduardo Cortes Gomez, et al.
Pageof 28